IBIO iBio Inc

$IBIO waiting on some money to move accounts but when it lands and this POS is still under a buck this week I’ll buy more like an absolute bozo

$IBIO 610 preclinical data (10/1) 610 IND filing (before EOY) 600 P1 interim data (1Q 2027) 610 first patient dosing (1H 2027) 800 IND filing (1H 2027) Purchased by Lilly (TBD) Let’s get this POS going FFS

$IBIO BioWorld published an article yesterday titled “iBio’s IBIO-610 reshapes weight loss composition.” It specifically discusses the EASD work and notes that human genetics/RNA-silencing evidence supports reduced Activin E–ALK7 signaling as a potentially favorable metabolic mechanism, before discussing iBio's obese-NHP results.

$IBIO Bought more before the weekend. I don’t think it will be down at this level much longer. I’m feeling very comfortable with my cost average

$IBIO Bought more today. Down to $3.01 average and still optimistic. October could get interesting.

$IBIO Just need some positive news to come out and this thing will jump. Until then Im just going to keep hanging on for dear life.

$IBIO I love seeing all the RS posts already, the stock has been under $1 for literally 2 days. It takes being under $1 for 30 consecutive trading days before a non compliance notice will be sent. And yes, this company has done Reverse split in the past, which usually were a couple months after receiving the notice. Months, not days.

$IBIO schedule of events: • Thursday, October 1, 2026 — EASD Annual Meeting, Milan • Monday, October 12, 2026 — Drug Discovery US, San Diego • Tuesday, November 10, 2026 — Guggenheim 3rd Annual Healthcare Innovation Conference, Boston • Saturday, November 14, 2026 — Obesity Week, Washington, D.C. • Monday, November 16, 2026 — Jefferies, London • Monday, November 16, 2026 — PEGS Europe, Lisbon • Tuesday, December 1, 2026 — Piper Sandler 38th Annual Healthcare Conference, New York • Tuesday, December 1, 2026 — Amylin-Based Therapeutics Summit, Boston • Monday, January 11, 2027 — 45th Annual J.P. Morgan Healthcare Conference, San Francisco

$IBIO Future potential, clearly underscored by the high-profile recruitment of Dr. Molly Carr as Chief Medical Officer. Under the leadership of CEO and CSO Martin Brenner, iBio has aggressively pivoted from its legacy footprint into an AI-driven, clinical-stage innovator tackling the massive obesity and cardiometabolic market. Dr. Carr’s decision to join the company directly from her role as Clinical Head of Eli Lilly’s Insulin and Glucagon Franchise serves as a powerful validation of iBio's underlying science. Top-tier biopharma executives do not abandon massive pharmaceutical platforms for stagnant ventures; rather, her appointment proves that iBio's targeted antibody platform holds genuine, market-disrupting promise capable of rewriting the company’s trajectory.

$IBIO Are we in direct competition with Viking Therapeutics? Trading over 40 dollars and ibio sitting at a buck and change? They published news today.

$IBIO um, yeah. same old playbook in use. not a company meant to produce anything, but bag holder loses. I am one and tried to warn people, but that was perceived as, what was it? oh yeah, "whining"

$IBIO What I'm watching is two computers battleing over one penny. Every uptick followed by a sell. I'm hoping October is more fruitful.

$IBIO Well, I just bought more. Finally got my average solidly below $3. I’m not worried with this low volume. The company is worth far more than this. Let’s go, Martin!

$IBIO Big pharma acquisitions are hitting record highs to combat impending patent cliffs. r NPVhttps://share.google/b0eXtryyDZiSW5u0c

$IBIO YO MARTY YOU BALD FK YOUVE BEEN AWFULLY QUIET AND THE SP IS CRASHING AND YOUR SHAREHOLDERS CONTINUE TO EAT POO ANYTHING YOUD LIKE TO SAY OR DO TO TRY AND HELP THE SITUATION??? BALD FK

$IBIO Any old timers here remember Rambo? We could use his words of wisdom now.....good luck everybody.

$IBIO contrast between Lilly stock and Ibio. Ibio discloses, they had superior drug discovery to Eli Lilly and created a drug they could not. that’s the key thing for biotechs. Of course, Lily uses headlines and Ibio discloses it the last sentence of article about something else. And 4 years after the fact. When the stock is $300 lower. 

$IBIO Maybe they should have a meeting and vote for what ratio RS they want Fuks Martin is an air head

$IBIO so the ai IP is crap or it has already been replicated or should we say different versions built for other pharms and is inferior 👎

$IBIO a company with potentially a breakthrough drug and weight loss and muscle gain, and nobody wants to talk about it you must’ve all sold and went away. Did the Germans give up when they bomb Pearl Harbor? Hell no